APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hydroxychloroquine Sulphate

Hydroxychloroquine sulfate was listed in the United States in 1955 and used in malaria, rheumatoid arthritis and lupus erythematosus. The variety has been approved in more than 70 countries such as Canada, France, Germany, Australia, China, Japan, etc.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Hydroxychloroquine sulfate was listed in the United States in 1955 and used in malaria, rheumatoid arthritis and lupus erythematosus. The variety has been approved in more than 70 countries such as Canada, France, Germany, Australia, China, Japan, etc.

Hydroxychloroquine sulfate, initially an anti malarial drug, was found to have mild immunosuppressive and immunomodulatory effects in clinical practice.

Selected research

Market Structure

Global Hydroxychloroquine Sulphate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

28 December 2025195 pages

Choose your research edition.

Industry ResearchHydroxychloroquine Sulphate Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Hydroxychloroquine Sulphate Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Hydroxychloroquine Sulphate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hydroxychloroquine Sulphate Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Hydroxychloroquine Sulphate Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

Hydroxychloroquine sulfate was listed in the United States in 1955 and used in malaria, rheumatoid arthritis and lupus erythematosus. The variety has been approved in more than 70 countries such as Canada, France, Germany, Australia, China, Japan, etc.

Hydroxychloroquine sulfate, initially an anti malarial drug, was found to have mild immunosuppressive and immunomodulatory effects in clinical practice.

The major producers in the industry are Sanofi, Novartis and Shanghai Zhongxisanwei, with their revenue ratios of 36.07%, 14.20% and 15.08% respectively in 2019.

Read the full market overview

This report provides an overview of the global Hydroxychloroquine Sulphate market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Hydroxychloroquine Sulphate and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Hydroxychloroquine Sulphate sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Hydroxychloroquine Sulphate market size, projected growth trends, production technologies, key applications, and end-use industries.

Hydroxychloroquine Sulphate Segment by Company

Sanofi

Novartis

Shanghai Zhongxisanwei

Teva

Zydus Cadila

Mylan

Apotex

Advanz Pharma

Sun Pharma

Kyung Poong

Ipca Laboratories

Hanlim Pharmaceutical

Bristol Laboratories

Hydroxychloroquine Sulphate Segment by Type

100mg

200mg

Others

Hydroxychloroquine Sulphate Segment by Application

Lupus Erythematosus

Rheumatoid Arthritis

Others

Hydroxychloroquine Sulphate Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hydroxychloroquine Sulphate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hydroxychloroquine Sulphate and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hydroxychloroquine Sulphate.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Hydroxychloroquine Sulphate market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Hydroxychloroquine Sulphate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Hydroxychloroquine Sulphate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Hydroxychloroquine Sulphate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Hydroxychloroquine Sulphate Industry Trends Table 2. Hydroxychloroquine Sulphate Industry Drivers Table 3. Hydroxychloroquine Sulphate Industry Opportunities and Challenges Table 4. Hydroxychloroquine Sulphate Industry Restraints Table 5. Global Hydroxychloroquine Sulphate Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Hydroxychloroquine Sulphate Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Hydroxychloroquine Sulphate Sales by Manufacturers (K Pcs) & (2021-2026) Table 8. Global Hydroxychloroquine Sulphate Sales Market Share by Manufacturers Table 9. Global Hydroxychloroquine Sulphate Average Sales Price (US$/K Pcs) of Manufacturers (2021-2026) Table 10. Global Hydroxychloroquine Sulphate Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Hydroxychloroquine Sulphate Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Hydroxychloroquine Sulphate Manufacturers, Product Type & Application Table 13. Global Hydroxychloroquine Sulphate Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Hydroxychloroquine Sulphate by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 100mg Table 17. Major Manufacturers of 200mg Table 18. Major Manufacturers of Others Table 19. Global Hydroxychloroquine Sulphate Sales by Type 2021 VS 2025 VS 2032 (K Pcs) Table 20. Global Hydroxychloroquine Sulphate Sales by Type (2021-2026) & (K Pcs) Table 21. Global Hydroxychloroquine Sulphate Sales by Type (2027-2032) & (K Pcs) Table 22. Global Hydroxychloroquine Sulphate Sales Market Share by Type (2021-2026) Table 23. Global Hydroxychloroquine Sulphate Sales Market Share by Type (2027-2032) Table 24. Global Hydroxychloroquine Sulphate Revenue by Type 2021 VS 2025 VS 2032 (K Pcs) Table 25. Global Hydroxychloroquine Sulphate Revenue by Type (2021-2026) & (K Pcs) Table 26. Global Hydroxychloroquine Sulphate Revenue by Type (2027-2032) & (K Pcs) Table 27. Global Hydroxychloroquine Sulphate Revenue Market Share by Type (2021-2026) Table 28. Global Hydroxychloroquine Sulphate Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Lupus Erythematosus Table 30. Major Manufacturers of Rheumatoid Arthritis Table 31. Major Manufacturers of Others Table 32. Global Hydroxychloroquine Sulphate Sales by Application 2021 VS 2025 VS 2032 (K Pcs) Table 33. Global Hydroxychloroquine Sulphate Sales by Application (2021-2026) & (K Pcs) Table 34. Global Hydroxychloroquine Sulphate Sales by Application (2027-2032) & (K Pcs) Table 35. Global Hydroxychloroquine Sulphate Sales Market Share by Application (2021-2026) Table 36. Global Hydroxychloroquine Sulphate Sales Market Share by Application (2027-2032) Table 37. Global Hydroxychloroquine Sulphate Revenue by Application 2021 VS 2025 VS 2032 (K Pcs) Table 38. Global Hydroxychloroquine Sulphate Revenue by Application (2021-2026) & (K Pcs) Table 39. Global Hydroxychloroquine Sulphate Revenue by Application (2027-2032) & (K Pcs) Table 40. Global Hydroxychloroquine Sulphate Revenue Market Share by Application (2021-2026) Table 41. Global Hydroxychloroquine Sulphate Revenue Market Share by Application (2027-2032) Table 42. Global Hydroxychloroquine Sulphate Sales by Region: 2021 VS 2025 VS 2032 (K Pcs) Table 43. Global Hydroxychloroquine Sulphate Sales by Region (2021-2026) & (K Pcs) Table 44. Global Hydroxychloroquine Sulphate Sales Market Share by Region (2021-2026) Table 45. Global Hydroxychloroquine Sulphate Sales Forecasted by Region (2027-2032) & (K Pcs) Table 46. Global Hydroxychloroquine Sulphate Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Hydroxychloroquine Sulphate Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Pcs) Table 48. North America Hydroxychloroquine Sulphate Sales by Country (2021-2026) & (K Pcs) Table 49. North America Hydroxychloroquine Sulphate Sales by Country (2027-2032) & (K Pcs) Table 50. Europe Hydroxychloroquine Sulphate Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Pcs) Table 51. Europe Hydroxychloroquine Sulphate Sales by Country (2021-2026) & (K Pcs) Table 52. Europe Hydroxychloroquine Sulphate Sales by Country (2027-2032) & (K Pcs) Table 53. Asia Pacific Hydroxychloroquine Sulphate Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Pcs) Table 54. Asia Pacific Hydroxychloroquine Sulphate Sales by Country (2021-2026) & (K Pcs) Table 55. Asia Pacific Hydroxychloroquine Sulphate Sales by Country (2027-2032) & (K Pcs) Table 56. South America, Middle East and Africa Hydroxychloroquine Sulphate Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Pcs) Table 57. South America, Middle East and Africa Hydroxychloroquine Sulphate Sales by Country (2021-2026) & (K Pcs) Table 58. South America, Middle East and Africa Hydroxychloroquine Sulphate Sales by Country (2027-2032) & (K Pcs) Table 59. Global Hydroxychloroquine Sulphate Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Hydroxychloroquine Sulphate Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Hydroxychloroquine Sulphate Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Hydroxychloroquine Sulphate Revenue Market Share by Region (2021-2026) Table 63. Global Hydroxychloroquine Sulphate Revenue Market Share by Region (2027-2032) Table 64. Sanofi Company Information Table 65. Sanofi Business Overview Table 66. Sanofi Hydroxychloroquine Sulphate Sales (K Pcs), Price (US$/K Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Sanofi Hydroxychloroquine Sulphate Product Portfolio Table 68. Sanofi Recent Development Table 69. Novartis Company Information Table 70. Novartis Business Overview Table 71. Novartis Hydroxychloroquine Sulphate Sales (K Pcs), Price (US$/K Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Novartis Hydroxychloroquine Sulphate Product Portfolio Table 73. Novartis Recent Development Table 74. Shanghai Zhongxisanwei Company Information Table 75. Shanghai Zhongxisanwei Business Overview Table 76. Shanghai Zhongxisanwei Hydroxychloroquine Sulphate Sales (K Pcs), Price (US$/K Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Shanghai Zhongxisanwei Hydroxychloroquine Sulphate Product Portfolio Table 78. Shanghai Zhongxisanwei Recent Development Table 79. Teva Company Information Table 80. Teva Business Overview Table 81. Teva Hydroxychloroquine Sulphate Sales (K Pcs), Price (US$/K Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Teva Hydroxychloroquine Sulphate Product Portfolio Table 83. Teva Recent Development Table 84. Zydus Cadila Company Information Table 85. Zydus Cadila Business Overview Table 86. Zydus Cadila Hydroxychloroquine Sulphate Sales (K Pcs), Price (US$/K Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Zydus Cadila Hydroxychloroquine Sulphate Product Portfolio Table 88. Zydus Cadila Recent Development Table 89. Mylan Company Information Table 90. Mylan Business Overview Table 91. Mylan Hydroxychloroquine Sulphate Sales (K Pcs), Price (US$/K Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Mylan Hydroxychloroquine Sulphate Product Portfolio Table 93. Mylan Recent Development Table 94. Apotex Company Information Table 95. Apotex Business Overview Table 96. Apotex Hydroxychloroquine Sulphate Sales (K Pcs), Price (US$/K Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Apotex Hydroxychloroquine Sulphate Product Portfolio Table 98. Apotex Recent Development Table 99. Advanz Pharma Company Information Table 100. Advanz Pharma Business Overview Table 101. Advanz Pharma Hydroxychloroquine Sulphate Sales (K Pcs), Price (US$/K Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Advanz Pharma Hydroxychloroquine Sulphate Product Portfolio Table 103. Advanz Pharma Recent Development Table 104. Sun Pharma Company Information Table 105. Sun Pharma Business Overview Table 106. Sun Pharma Hydroxychloroquine Sulphate Sales (K Pcs), Price (US$/K Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Sun Pharma Hydroxychloroquine Sulphate Product Portfolio Table 108. Sun Pharma Recent Development Table 109. Kyung Poong Company Information Table 110. Kyung Poong Business Overview Table 111. Kyung Poong Hydroxychloroquine Sulphate Sales (K Pcs), Price (US$/K Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Kyung Poong Hydroxychloroquine Sulphate Product Portfolio Table 113. Kyung Poong Recent Development Table 114. Ipca Laboratories Company Information Table 115. Ipca Laboratories Business Overview Table 116. Ipca Laboratories Hydroxychloroquine Sulphate Sales (K Pcs), Price (US$/K Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Ipca Laboratories Hydroxychloroquine Sulphate Product Portfolio Table 118. Ipca Laboratories Recent Development Table 119. Hanlim Pharmaceutical Company Information Table 120. Hanlim Pharmaceutical Business Overview Table 121. Hanlim Pharmaceutical Hydroxychloroquine Sulphate Sales (K Pcs), Price (US$/K Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Hanlim Pharmaceutical Hydroxychloroquine Sulphate Product Portfolio Table 123. Hanlim Pharmaceutical Recent Development Table 124. Bristol Laboratories Company Information Table 125. Bristol Laboratories Business Overview Table 126. Bristol Laboratories Hydroxychloroquine Sulphate Sales (K Pcs), Price (US$/K Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Bristol Laboratories Hydroxychloroquine Sulphate Product Portfolio Table 128. Bristol Laboratories Recent Development Table 129. Key Raw Materials Table 130. Raw Materials Key Suppliers Table 131. Hydroxychloroquine Sulphate Distributors List Table 132. Hydroxychloroquine Sulphate Customers List Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources Table 136. Primary Sources List of Figures Figure 1. Hydroxychloroquine Sulphate Product Image Figure 2. Global Hydroxychloroquine Sulphate Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hydroxychloroquine Sulphate Market Size (2021-2032) & (US$ Million) Figure 4. Global Hydroxychloroquine Sulphate Sales (2021-2032) & (K Pcs) Figure 5. Global Hydroxychloroquine Sulphate Average Price (US$/K Pcs) & (2021-2032) Figure 6. Global Top 5 and 10 Hydroxychloroquine Sulphate Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 100mg Image Figure 9. 200mg Image Figure 10. Others Image Figure 11. Global Hydroxychloroquine Sulphate Sales by Type (2021 VS 2025 VS 2032) & (K Pcs) Figure 12. Global Hydroxychloroquine Sulphate Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Hydroxychloroquine Sulphate Sales Market Share by Type (2021-2032) Figure 14. Global Hydroxychloroquine Sulphate Revenue by Type (2021 VS 2025 VS 2032) & (K Pcs) Figure 15. Global Hydroxychloroquine Sulphate Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Hydroxychloroquine Sulphate Revenue Market Share by Type (2021-2032) Figure 17. Lupus Erythematosus Image Figure 18. Rheumatoid Arthritis Image Figure 19. Others Image Figure 20. Global Hydroxychloroquine Sulphate Sales by Application (2021 VS 2025 VS 2032) & (K Pcs) Figure 21. Global Hydroxychloroquine Sulphate Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Hydroxychloroquine Sulphate Sales Market Share by Application (2021-2032) Figure 23. Global Hydroxychloroquine Sulphate Revenue by Application (2021 VS 2025 VS 2032) & (K Pcs) Figure 24. Global Hydroxychloroquine Sulphate Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Hydroxychloroquine Sulphate Revenue Market Share by Application (2021-2032) Figure 26. North America Hydroxychloroquine Sulphate Sales and Growth Rate (2021-2032) & (K Pcs) Figure 27. North America Hydroxychloroquine Sulphate Sales Market Share by Country (2021-2032) Figure 28. U.S. Hydroxychloroquine Sulphate Sales and Growth Rate (2021-2032) & (K Pcs) Figure 29. Canada Hydroxychloroquine Sulphate Sales and Growth Rate (2021-2032) & (K Pcs) Figure 30. Mexico Hydroxychloroquine Sulphate Sales and Growth Rate (2021-2032) & (K Pcs) Figure 31. Europe Hydroxychloroquine Sulphate Sales and Growth Rate (2021-2032) & (K Pcs) Figure 32. Europe Hydroxychloroquine Sulphate Sales Market Share by Country (2021-2032) Figure 33. Germany Hydroxychloroquine Sulphate Sales and Growth Rate (2021-2032) & (K Pcs) Figure 34. France Hydroxychloroquine Sulphate Sales and Growth Rate (2021-2032) & (K Pcs) Figure 35. U.K. Hydroxychloroquine Sulphate Sales and Growth Rate (2021-2032) & (K Pcs) Figure 36. Italy Hydroxychloroquine Sulphate Sales and Growth Rate (2021-2032) & (K Pcs) Figure 37. Netherlands Hydroxychloroquine Sulphate Sales and Growth Rate (2021-2032) & (K Pcs) Figure 38. Asia Pacific Hydroxychloroquine Sulphate Sales and Growth Rate (2021-2032) & (K Pcs) Figure 39. Asia Pacific Hydroxychloroquine Sulphate Sales Market Share by Country (2021-2032) Figure 40. China Hydroxychloroquine Sulphate Sales and Growth Rate (2021-2032) & (K Pcs) Figure 41. Japan Hydroxychloroquine Sulphate Sales and Growth Rate (2021-2032) & (K Pcs) Figure 42. South Korea Hydroxychloroquine Sulphate Sales and Growth Rate (2021-2032) & (K Pcs) Figure 43. Southeast Asia Hydroxychloroquine Sulphate Sales and Growth Rate (2021-2032) & (K Pcs) Figure 44. India Hydroxychloroquine Sulphate Sales and Growth Rate (2021-2032) & (K Pcs) Figure 45. Australia Hydroxychloroquine Sulphate Sales and Growth Rate (2021-2032) & (K Pcs) Figure 46. South America, Middle East and Africa Hydroxychloroquine Sulphate Sales and Growth Rate (2021-2032) & (K Pcs) Figure 47. South America, Middle East and Africa Hydroxychloroquine Sulphate Sales Market Share by Country (2021-2032) Figure 48. Brazil Hydroxychloroquine Sulphate Sales and Growth Rate (2021-2032) & (K Pcs) Figure 49. South Africa Hydroxychloroquine Sulphate Sales and Growth Rate (2021-2032) & (K Pcs) Figure 50. Saudi Arabia Hydroxychloroquine Sulphate Sales and Growth Rate (2021-2032) & (K Pcs) Figure 51. Turkey Hydroxychloroquine Sulphate Sales and Growth Rate (2021-2032) & (K Pcs) Figure 52. Argentina Hydroxychloroquine Sulphate Sales and Growth Rate (2021-2032) & (K Pcs) Figure 53. UAE Hydroxychloroquine Sulphate Sales and Growth Rate (2021-2032) & (K Pcs) Figure 54. Egypt Hydroxychloroquine Sulphate Sales and Growth Rate (2021-2032) & (K Pcs) Figure 55. Chile Hydroxychloroquine Sulphate Sales and Growth Rate (2021-2032) & (K Pcs) Figure 56. Global Hydroxychloroquine Sulphate Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Hydroxychloroquine Sulphate Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Hydroxychloroquine Sulphate Revenue (2021-2032) & (US$ Million) Figure 59. North America Hydroxychloroquine Sulphate Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Hydroxychloroquine Sulphate Revenue (2021-2032) & (US$ Million) Figure 61. Europe Hydroxychloroquine Sulphate Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Hydroxychloroquine Sulphate Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Hydroxychloroquine Sulphate Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Hydroxychloroquine Sulphate Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Hydroxychloroquine Sulphate Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Hydroxychloroquine Sulphate Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Hydroxychloroquine Sulphate Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 100mg
  • 200mg
  • Others
Applications
  • Lupus Erythematosus
  • Rheumatoid Arthritis
  • Others
Companies covered
  • Sanofi
  • Novartis
  • Shanghai Zhongxisanwei
  • Teva
  • Zydus Cadila
  • Mylan
  • Apotex
  • Advanz Pharma
  • Sun Pharma
  • Kyung Poong
  • Ipca Laboratories
  • Hanlim Pharmaceutical
  • Bristol Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Hydroxychloroquine Sulphate Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Hydroxychloroquine Sulphate Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Hydroxychloroquine Sulphate Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Hydroxychloroquine Sulphate Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Hydroxychloroquine Sulphate Market Dynamics
  1. 2.1 Hydroxychloroquine Sulphate Industry Trends
  2. 2.2 Hydroxychloroquine Sulphate Industry Drivers
  3. 2.3 Hydroxychloroquine Sulphate Industry Opportunities and Challenges
  4. 2.4 Hydroxychloroquine Sulphate Industry Restraints
3 Hydroxychloroquine Sulphate Market by Manufacturers
  1. 3.1 Global Hydroxychloroquine Sulphate Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Hydroxychloroquine Sulphate Sales by Manufacturers (2021-2026)
  3. 3.3 Global Hydroxychloroquine Sulphate Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Hydroxychloroquine Sulphate Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Hydroxychloroquine Sulphate Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Hydroxychloroquine Sulphate Manufacturers, Product Type & Application
  7. 3.7 Global Hydroxychloroquine Sulphate Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Hydroxychloroquine Sulphate Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Hydroxychloroquine Sulphate Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Hydroxychloroquine Sulphate Tier 1, Tier 2, and Tier 3
4 Hydroxychloroquine Sulphate Market by Type
  1. 4.1 Hydroxychloroquine Sulphate Type Introduction
  2. 4.1.1 100mg
  3. 4.1.2 200mg
  4. 4.1.3 Others
  5. 4.2 Global Hydroxychloroquine Sulphate Sales by Type
  6. 4.2.1 Global Hydroxychloroquine Sulphate Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Hydroxychloroquine Sulphate Sales by Type (2021-2032)
  8. 4.2.3 Global Hydroxychloroquine Sulphate Sales Market Share by Type (2021-2032)
  9. 4.3 Global Hydroxychloroquine Sulphate Revenue by Type
  10. 4.3.1 Global Hydroxychloroquine Sulphate Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Hydroxychloroquine Sulphate Revenue by Type (2021-2032)
  12. 4.3.3 Global Hydroxychloroquine Sulphate Revenue Market Share by Type (2021-2032)
5 Hydroxychloroquine Sulphate Market by Application
  1. 5.1 Hydroxychloroquine Sulphate Application Introduction
  2. 5.1.1 Lupus Erythematosus
  3. 5.1.2 Rheumatoid Arthritis
  4. 5.1.3 Others
  5. 5.2 Global Hydroxychloroquine Sulphate Sales by Application
  6. 5.2.1 Global Hydroxychloroquine Sulphate Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Hydroxychloroquine Sulphate Sales by Application (2021-2032)
  8. 5.2.3 Global Hydroxychloroquine Sulphate Sales Market Share by Application (2021-2032)
  9. 5.3 Global Hydroxychloroquine Sulphate Revenue by Application
  10. 5.3.1 Global Hydroxychloroquine Sulphate Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Hydroxychloroquine Sulphate Revenue by Application (2021-2032)
  12. 5.3.3 Global Hydroxychloroquine Sulphate Revenue Market Share by Application (2021-2032)
6 Global Hydroxychloroquine Sulphate Sales by Region
  1. 6.1 Global Hydroxychloroquine Sulphate Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Hydroxychloroquine Sulphate Sales by Region (2021-2032)
  3. 6.2.1 Global Hydroxychloroquine Sulphate Sales by Region (2021-2026)
  4. 6.2.2 Global Hydroxychloroquine Sulphate Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Hydroxychloroquine Sulphate Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Hydroxychloroquine Sulphate Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Hydroxychloroquine Sulphate Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Hydroxychloroquine Sulphate Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Hydroxychloroquine Sulphate Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Hydroxychloroquine Sulphate Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Hydroxychloroquine Sulphate Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Hydroxychloroquine Sulphate Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Hydroxychloroquine Sulphate Revenue by Region
  1. 7.1 Global Hydroxychloroquine Sulphate Revenue by Region
  2. 7.1.1 Global Hydroxychloroquine Sulphate Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Hydroxychloroquine Sulphate Revenue by Region (2021-2026)
  4. 7.1.3 Global Hydroxychloroquine Sulphate Revenue by Region (2027-2032)
  5. 7.1.4 Global Hydroxychloroquine Sulphate Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Hydroxychloroquine Sulphate Revenue (2021-2032)
  8. 7.2.2 North America Hydroxychloroquine Sulphate Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Hydroxychloroquine Sulphate Revenue (2021-2032)
  11. 7.3.2 Europe Hydroxychloroquine Sulphate Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Hydroxychloroquine Sulphate Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Hydroxychloroquine Sulphate Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Hydroxychloroquine Sulphate Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Hydroxychloroquine Sulphate Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi
  2. 8.1.1 Sanofi Company Information
  3. 8.1.2 Sanofi Business Overview
  4. 8.1.3 Sanofi Hydroxychloroquine Sulphate Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Hydroxychloroquine Sulphate Product Portfolio
  6. 8.1.5 Sanofi Recent Developments
  7. 8.2 Novartis
  8. 8.2.1 Novartis Company Information
  9. 8.2.2 Novartis Business Overview
  10. 8.2.3 Novartis Hydroxychloroquine Sulphate Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Novartis Hydroxychloroquine Sulphate Product Portfolio
  12. 8.2.5 Novartis Recent Developments
  13. 8.3 Shanghai Zhongxisanwei
  14. 8.3.1 Shanghai Zhongxisanwei Company Information
  15. 8.3.2 Shanghai Zhongxisanwei Business Overview
  16. 8.3.3 Shanghai Zhongxisanwei Hydroxychloroquine Sulphate Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Shanghai Zhongxisanwei Hydroxychloroquine Sulphate Product Portfolio
  18. 8.3.5 Shanghai Zhongxisanwei Recent Developments
  19. 8.4 Teva
  20. 8.4.1 Teva Company Information
  21. 8.4.2 Teva Business Overview
  22. 8.4.3 Teva Hydroxychloroquine Sulphate Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Teva Hydroxychloroquine Sulphate Product Portfolio
  24. 8.4.5 Teva Recent Developments
  25. 8.5 Zydus Cadila
  26. 8.5.1 Zydus Cadila Company Information
  27. 8.5.2 Zydus Cadila Business Overview
  28. 8.5.3 Zydus Cadila Hydroxychloroquine Sulphate Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Zydus Cadila Hydroxychloroquine Sulphate Product Portfolio
  30. 8.5.5 Zydus Cadila Recent Developments
  31. 8.6 Mylan
  32. 8.6.1 Mylan Company Information
  33. 8.6.2 Mylan Business Overview
  34. 8.6.3 Mylan Hydroxychloroquine Sulphate Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Mylan Hydroxychloroquine Sulphate Product Portfolio
  36. 8.6.5 Mylan Recent Developments
  37. 8.7 Apotex
  38. 8.7.1 Apotex Company Information
  39. 8.7.2 Apotex Business Overview
  40. 8.7.3 Apotex Hydroxychloroquine Sulphate Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Apotex Hydroxychloroquine Sulphate Product Portfolio
  42. 8.7.5 Apotex Recent Developments
  43. 8.8 Advanz Pharma
  44. 8.8.1 Advanz Pharma Company Information
  45. 8.8.2 Advanz Pharma Business Overview
  46. 8.8.3 Advanz Pharma Hydroxychloroquine Sulphate Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Advanz Pharma Hydroxychloroquine Sulphate Product Portfolio
  48. 8.8.5 Advanz Pharma Recent Developments
  49. 8.9 Sun Pharma
  50. 8.9.1 Sun Pharma Company Information
  51. 8.9.2 Sun Pharma Business Overview
  52. 8.9.3 Sun Pharma Hydroxychloroquine Sulphate Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Sun Pharma Hydroxychloroquine Sulphate Product Portfolio
  54. 8.9.5 Sun Pharma Recent Developments
  55. 8.10 Kyung Poong
  56. 8.10.1 Kyung Poong Company Information
  57. 8.10.2 Kyung Poong Business Overview
  58. 8.10.3 Kyung Poong Hydroxychloroquine Sulphate Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Kyung Poong Hydroxychloroquine Sulphate Product Portfolio
  60. 8.10.5 Kyung Poong Recent Developments
  61. 8.11 Ipca Laboratories
  62. 8.11.1 Ipca Laboratories Company Information
  63. 8.11.2 Ipca Laboratories Business Overview
  64. 8.11.3 Ipca Laboratories Hydroxychloroquine Sulphate Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Ipca Laboratories Hydroxychloroquine Sulphate Product Portfolio
  66. 8.11.5 Ipca Laboratories Recent Developments
  67. 8.12 Hanlim Pharmaceutical
  68. 8.12.1 Hanlim Pharmaceutical Company Information
  69. 8.12.2 Hanlim Pharmaceutical Business Overview
  70. 8.12.3 Hanlim Pharmaceutical Hydroxychloroquine Sulphate Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Hanlim Pharmaceutical Hydroxychloroquine Sulphate Product Portfolio
  72. 8.12.5 Hanlim Pharmaceutical Recent Developments
  73. 8.13 Bristol Laboratories
  74. 8.13.1 Bristol Laboratories Company Information
  75. 8.13.2 Bristol Laboratories Business Overview
  76. 8.13.3 Bristol Laboratories Hydroxychloroquine Sulphate Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Bristol Laboratories Hydroxychloroquine Sulphate Product Portfolio
  78. 8.13.5 Bristol Laboratories Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Hydroxychloroquine Sulphate Value Chain Analysis
  2. 9.1.1 Hydroxychloroquine Sulphate Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Hydroxychloroquine Sulphate Production Mode & Process
  6. 9.2 Hydroxychloroquine Sulphate Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Hydroxychloroquine Sulphate Distributors
  9. 9.2.3 Hydroxychloroquine Sulphate Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst